Where do Viking Therapeutics's ratios come from?

Every ratio is computed from Viking Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-47.3%-29.4pp	-17.9%+16.9pp	-34.8%+4.9pp	-39.7%-15.0pp
Return on assets	-44.3%-27.1pp	-17.2%+14.8pp	-32%+4.3pp	-36.3%-12.8pp
Return on invested capital	-59.2%-33.0pp	-26.3%+23.6pp	-49.9%-0.6pp	-49.2%-20.8pp
Efficiency
Asset turnover	0×—	0×—	0×—	0×—
Liquidity
Current ratio	9.3×-23.8×	33.1×+13.9×	19.2×+11.6×	7.6×-16.4×
Quick ratio	9.3×-23.8×	33.1×+13.9×	19.2×+11.6×	7.6×-16.4×
Cash ratio	2.2×+1.2×	1×-1.9×	2.9×+1.2×	1.7×-1.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Interest coverage	-11.7×-8.0×	-3.7×+3.0×	-6.7×+37.6×	-44.3×+34.8×
Per Share
Book value per share	$5.67-29.7%	$8.07+119%	$3.69+95.3%	$1.89-27.7%
Valuation
Market capitalization	$3.98B-11.3%	$4.48B+141%	$1.86B+158%	$720.87M+100%
Enterprise value	$3.81B-14.5%	$4.46B+146%	$1.81B+164%	$685.8M+106%
Price / book	6.2×+1.1×	5.1×-0.3×	5.3×+0.4×	5×+3.2×
Earnings yield	-9%-6.6pp	-2.5%+2.2pp	-4.6%+4.9pp	-9.6%+5.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Viking Therapeutics's ratios come from?: Every ratio is computed from Viking Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.